| abstract |
The present invention relates to an acid addition salt of linezolid with naphthalene- 1,5-disulfonic acid or with p-toluene sulfonic acid such as linezolid mono-naphtalene-1,5- disulfonate (linezolid hydrogennapadisylate), linezolid hemi-naphthalene-l,5-disulfonate (linezolide napadisylate) and linezolid p-toluene sulfonate (linezolid tosylate), to pharmaceutical compositions comprising them, to a process for making them, to a process for making linezolid base, to the use in making a medicine and use in medicine. |